The Future of the Atopic Dermatitis Market
Although sometimes conflated as one condition, psoriasis and atopic dermatitis (AD) differ from each other in clinical presentation yet share similar guidelines, mental health repercussions, and therapeutic options. As psoriasis-focused treatment modalities have multiplied over the past few years due to a spike in prevalence, similar growth is currently being witnessed in the AD medication […]
Psoriasis and Its Treatment with New Generation Biologics
By: Sangeeta Chakraborty, Ph.D. | Research Associate at National Jewish Health Overview Psoriasis is one of the most common non-communicable skin disorders with a worldwide prevalence of about 2% but can vary from 0.5 to 11%, depending on the geographic region. Since psoriasis pathogenesis is quite complex and the exact mechanisms of its cause are […]
Updated COVID-19 Recommendations for Patients with Psoriatic Disease
With the novel coronavirus outbreak continuing to evolve as a public health concern, the need for tailored medical guidance and updated clinical recommendations is emerging across specialties. General guidelines issued by the CDC and WHO, such as social distancing and self-isolation when possible, apply to all individuals. However, the coronavirus may have challenging implications on the […]
Latest Clinical Practice Guidelines for Psoriasis Phototherapy TreatmentÂ
Out of the estimated 125 million individuals suffering from psoriasis worldwide, many may be capable of sufficiently managing the condition with the use of topical prescriptions alone. However, in the case of nearly 25% of patients these methods do not suffice – often, disease severity necessitates alternative options, including systemic and biologic treatments. These interventions are […]
Psoriasis Awareness Month: Advancements in Psoriasis Care
August marks the beginning of Psoriasis Awareness Month during which healthcare organizations, such as the National Psoriasis Foundation (NPF), raise awareness for the 8 million Americans affected by the disease. Often regarded as a simple skin condition, psoriasis has been linked to diabetes, heart disease, and other detrimental comorbidities in nearly a third of patients and […]
Pediatric Psoriasis and Obesity
A recent study published in JAMA Dermatology has found that children with psoriasis are at an increased risk of developing comorbidities compared to children without psoriasis, and obesity appears to be an important independent risk factor for the development of these cooccurring disorders. The study indicates that in addition to needing to manage the cutaneous […]
Can Diet Help in Psoriasis?
The Medical Board of the National Psoriasis Foundation has recently published a systematic literature review in JAMA Dermatology, with findings that indicate the efficacy and benefits of dietary weight loss—coupled with a hypocaloric diet—for overweight and obese patients with psoriasis. The recommendations further suggest that overweight or obese patients with psoriatic arthritis may benefit from […]
